930
S. Kobayashi et al. / Tetrahedron 65 (2009) 920–933
(MþþH, 68), 455 (Mþ, 22), 261 (100), 170 (44), 167 (33), 77 (Ph, 35).
HRMS-EI m/z [M]þ calcd for C33H29NO: 455.2249, found: 455.2250.
Ar), 7.60–7.63 (m, 2H, Ar); 13C NMR (126 MHz, CDCl3)
d 14.1 (CH3),
48.7 (CH), 60.47 (CH2), 60.53 (C), 115.7 (CH), 120.1 (CH), 125.9 (CH),
126.5 (2CH), 127.4 (CH), 127.7 (CH), 127.9 (CH), 128.30 (2CH), 128.32
(4CH), 128.5 (2CH), 129.1 (2CH), 129.2 (2CH), 130.4 (2CH), 136.9 (C),
137.2 (C), 138.2 (C), 138.6 (CH), 140.7 (C), 141.4 (C), 166.0 (C), 170.6
(C). HRMS-ESI m/z [MþNa]þ calcd for C34H29NNaO3: 522.2040,
found: 522.2045.
4.14. Typical procedure for [1,3]-sigmatropic rearrangement
of [2D2] cycloadduct 16 (Table 5, entry 1)
A solution of 16a (300 mg, 0.66 mmol) in xylene (30 mL) was
heated 140 ꢀC for 5 h, and then concentrated in vacuo. Purification
of the residue by flash chromatography [SiO2: EtOAc/hexane (1:4,
v/v)] followed by recrystallization from CH2Cl2/hexane (1:4, v/v)
4.16. Typical procedure for the second cycloaddition of
monoadducts 10 with methyl vinyl ketone (Table 7, entry 1)
yielded
6-(2-methyl-propenyl)-1,3,3,4-tetraphenyl-3,4-dihydro-
1H-pyridin-2-one (18a) (231 mg, 77%) as colorless crystals. Mp
Methyl vinyl ketone (0.06 mL, 0.7 mmol) was added to a xylene
(10 mL) solution of 10a (72 mg, 0.15 mmol) and heated at 140 ꢀC for
14 h. After being cooled to room temperature, the reaction mixture
was concentrated in vacuo. Purification of the residue by flash
chromatography [SiO2: EtOAc/hexane (1:4, v/v)] yielded a mixture
of 21a and 22a (61 mg, 74%, 17:83) as a colorless solid. Analytically
pure 22a was obtained by preparative HPLC [EtOAc/hexane (1:4,
v/v)].
192–193 ꢀC; IR (KBr): 3032, 2360, 1634, 1496, 1327, 1265, 756,
694 cmꢁ1
;
1H NMR (600 MHz, CDCl3)
d
1.45 (d, J¼1.1 Hz, 3H, Me),
1.55 (d, J¼1.1 Hz, 3H, Me), 4.22 (d, J¼6.8 Hz, 1H, H-4), 4.94–4.96 (m,
1H, H-7), 5.57 (dd, J¼1.1, 6.8 Hz, 1H, H-5), 5.58–6.61 (m, 2H, Ar),
6.85–6.90 (m, 2H, Ar), 6.93–6.97 (m, 3H, Ar), 7.05–7.15 (m, 5H,
Ar), 7.24–7.29 (m, 1H, Ar), 7.33–7.38 (m, 3H, Ar), 7.40–7.43 (m, 2H,
Ar), 7.67–7.77 (m, 2H, Ar); 13C NMR (150 MHz, CDCl3)
d 19.5 (CH3),
25.6 (CH3), 48.9 (CH), 60.7 (C), 111.0 (CH), 120.1 (CH), 125.6 (CH),
126.4 (2CH), 127.0 (CH), 127.3 (CH), 127.4 (CH), 128.08 (2CH), 128.09
(2CH), 128.3 (2CH), 128.6 (2CH), 128.9 (2CH), 129.2 (2CH), 130.5
(2CH), 137.0 (C), 138.0 (C), 138.6 (C), 139.1 (C), 141.3 (C), 142.0 (C),
170.9 (C). LRMS-EI m/z (ion, % relative intensity): 455 (Mþ, 42), 261
(100), 170 (54), 165 (22), 77 (Ph, 11). HRMS-ESI m/z [MþNa]þ calcd
for C33H29NNaO: 478.2141, found: 478.2141. Anal. Calcd for
C33H29NO: C, 87.00; H, 6.42; N, 3.07. Found: C, 87.12; H, 6.66; N,
3.05.
6-Acetyl-2-oxo-1,3,3,4-tetraphenyl-1,2,3,4,5,6,7,8-octahydro-
quinoline-7-carboxylic acid ethyl ester (22a): colorless crystaꢁls1; mp
;
1H
202–204 ꢀC; IR (KBr): 1732, 1716, 1680, 1496, 1346, 700 cm
NMR (600 MHz, C6D6)
d
0.70 (t, J¼7.2 Hz, 3H, Me(COOEt)), 1.73–1.78
(m, 2H, H-6, H-8), 1.80 (s, 3H, Me(COMe)), 2.02 (d, J¼17.4 Hz, 1H, H-
8), 2.24 (dd, J¼6.1, 17.4 Hz, 1H, H-5), 2.82 (ddd, J¼2.6, 2.6, 6.2 Hz,
1H, H-7), 2.86–2.92 (m, 1H, H-5), 3.66 (dq, J¼7.2, 10.5 Hz, 1H,
CH2(COOEt)), 3.74 (dq, J¼7.2, 10.5 Hz, 1H, CH2(COOEt)), 3.75 (s, 1H,
H-4), 6.84–6.88 (m, 3H, Ar), 6.94–7.09 (m, 11H, Ar), 7.21–7.24 (m,
3H, Ar), 7.29–7.34 (m, 1H, Ar), 7.62 (d, J¼7.7 Hz, 2H, Ar); 13C NMR
4.15. Typical procedure for the second cycloaddition of
monoadduct 11 with tetracyanoethylene (Table 6, entry 1)
(150 MHz, CDCl3)
d 13.8 (CH3), 26.6 (CH2), 27.4 (CH3), 29.3 (CH2),
39.5 (CH), 47.2 (CH), 53.8 (CH), 60.66 (C), 60.70 (CH2), 115.2 (C),
125.7 (CH), 126.4 (2CH), 127.2 (CH), 127.3 (CH), 127.8 (CH), 128.0
(CH), 128.1 (2CH), 128.2 (4CH), 129.1 (3CH), 129.3 (CH), 129.6 (CH),
130.0 (C), 130.3 (2CH), 138.0 (C), 138.3 (C), 141.2 (C), 141.9 (C), 170.5
(C), 171.4 (C), 207.6 (C). HRMS-ESI m/z: [MþNa]þ calcd for
C38H35NNaO4: 592.2458, found: 592.2457.
TCNE (10 mg, 0.08 mmol) was added to a solution of a mixture
of 10a and 11a (175 mg, 0.35 mol, 81:19) in CH2Cl2 (10 mL). The
reaction mixture was stirred at room temperature for 10 min and
then concentrated in vacuo. Purification of the residue by flash
chromatography [SiO2: EtOAc/hexane (3:7, v/v)] followed by
recrystallization from CH2Cl2/hexane (1:3, v/v) yielded 5,5,6,6-tetra-
cyano-2-oxo-1,3,3,7-tetraphenyl-1,2,3,4,4a,5,6,7-octahydroquinoline-
4-carboxylic acid ethyl ester (20a) (40 mg, 95% yield based on 11a)
as colorless crystals along with 3-(6-oxo-1,4,5,5-tetraphenyl-
1,4,5,6-tetrahydropyridin-2-yl)-acrylic acid ethyl ester (10a)
(136 mg, 96% recovery) as colorless crystals.
Compound 21a: 1H NMR (500 MHz, CDCl3)
Me(COOEt)).
d
1.18 (t, J¼7.1 Hz, 3H,
4.17. Typical procedure for the second cycloaddition of
monoadduct 18 with tetracyanoethylene (Table 8, entry 1)
Compound 20a: colorless crystals; mp 115–117 ꢀC; IR (KBr):
TCNE (17 mg, 0.13 mmol) was added to a solution of 18a (50 mg,
0.11 mmol) in 1,2-dichloroethane (5 mL). The reaction mixture was
heated at 83 ꢀC for 6.5 h, and then concentrated in vacuo. Purifi-
cation of the residue by flash chromatography [SiO2: EtOAc/hexane
(3:7, v/v)] followed by recrystallization from CH2Cl2/hexane (1:4,
v/v) yielded 7,7-dimethyl-2-oxo-1,3,3,4-tetraphenyl-1,2,3,4,4a,7-
hexahydroquinoline-5,5,6,6-tetracarbonitrile (23a) (64 mg, 99%) as
colorless crystals. Mp 200–201 ꢀC; IR (KBr): 3024, 1689, 1651, 1311,
1732, 1706, 1670, 1496, 1322, 1280, 1250, 1196, 702 cmꢁ1 1H NMR
;
(500 MHz, CDCl3)
d
0.89 (t, J¼7.0 Hz, 3H, Me(COOEt)), 3.62 (dq,
J¼7.0, 10.7 Hz, 1H, CH2(COOEt)), 3.94 (dq, J¼7.0, 10.7 Hz, 1H,
CH2(COOEt)), 4.17 (dd, J¼1.8, 3.4 Hz, 1H, H-7), 4.49 (ddd, J¼1.8, 1.8,
11.0 Hz, 1H, H-4a), 4.54 (d, J¼11.0 Hz, 1H, H-4), 4.94 (dd, J¼1.8,
3.4 Hz, 1H, H-8), 7.07–7.08 (d, J¼7.3 Hz, 2H, Ar), 7.19–7.21 (d,
J¼7.3 Hz, 2H, Ar), 7.26–7.48 (m, 14H, Ar), 7.53–7.54 (d, J¼7.3 Hz, 2H,
Ar); 13C NMR (126 MHz, CDCl3)
d
13.2 (CH3), 42.9 (CH), 43.5 (C), 46.4
748, 702 cmꢁ1; 1H NMR (500 MHz, CDCl3)
d 1.41 (s, 3H, Me), 1.59 (s,
(C), 46.9 (CH), 50.8 (CH), 61.1 (C), 62.8 (CH2), 109.4 (C), 109.8 (C),
109.9 (CH), 110.4 (C), 110.9 (C), 127.4 (2CH), 128.1 (2CH), 128.2 (CH),
128.3 (CH), 128.5 (2CH), 128.9 (CH), 129.3 (2CH), 129.4 (2CH), 129.5
(2CH), 130.20 (2CH), 130.26 (2CH), 130.30 (CH), 132.7 (C), 137.4 (C),
137.5 (C), 138.6 (C), 138.7 (C), 169.3 (C), 169.9 (C). LRMS-FAB m/z
(ion, % relative intensity): 628 (MþþH, 100), 500 (MþþHꢁTCNE,
37), 499 (MþꢁTCNE, 29), 165 (32). HRMS-FAB m/z [MþH]þ calcd for
C40H30N5O3: 628.2348, found: 628.2359.
3H, Me), 4.15 (dd, J¼1.8, 10.8 Hz, 1H, H-4a), 4.63 (d, J¼1.8 Hz, 1H, H-
8), 4.81 (d, J¼10.8 Hz, 1H, H-4), 6.44 (d, J¼6.4 Hz, 1H, Ar), 6.99 (d,
J¼7.7 Hz, 2H, Ar), 7.04–7.12 (m, 1H, Ar), 7.16–7.23 (m, 5H, Ar), 7.23–
7.32 (m, 4H, Ar), 7.35 (dd, J¼7.2, 7.9 Hz, 2H, Ar), 7.40 (dd, J¼7.4,
7.5 Hz, 1H, Ar), 7.49 (dd, J¼7.6, 7.9 Hz, 2H, Ar), 7.69 (d, J¼7.6 Hz, 2H,
Ar); 13C NMR (126 MHz, CDCl3)
d 26.0 (CH3), 30.1 (CH3), 39.7 (C),
43.1 (CH), 43.2 (C), 49.1 (CH), 51.4 (C), 62.4 (C), 109.7 (C), 110.2 (C),
110.46 (C), 110.53 (C), 115.1 (CH), 127.5 (3CH), 127.85 (3CH), 127.90
(CH), 127.93 (3CH), 128.0 (CH), 128.7 (CH), 129.6 (CH), 129.7 (2CH),
130.2 (3CH), 131.4 (2CH), 132.9 (C), 134.1 (C), 139.0 (C), 139.4 (C),
139.7 (C), 170.5 (C). LRMS-EI m/z (ion, % relative intensity): 583 (Mþ,
28), 455 (MþꢁTCNE, 5), 284 (41), 261 (25), 194 (Ph2CCO, 100), 166
(30), 165 (29), 77 (Ph, 10). HRMS-ESI m/z [MþNa]þ calcd for
C39H29N5NaO: 606.2264, found: 606.2236.
Compound 10a: colorless crystals; mp 171–173 ꢀC; IR (KBr):
1714, 1680, 1496, 1182, 698 cmꢁ1; 1H NMR (400 MHz, CDCl3)
d 1.16
(t, J¼7.1 Hz, 3H, Me(COOEt)), 4.05 (q, J¼7.1 Hz, 2H, CH2(COOEt)),
4.28 (d, J¼7.1 Hz, 1H, H-4), 5.73 (d, J¼15.9 Hz, 1H, H-2), 6.26 (d,
J¼7.1 Hz, 1H, H-3), 6.57–6.61 (m, 3H, Ar), 6.66–6.99 (m, 5H, Ar),
7.08–7.29 (m, 4H, Ar), 7.13 (d, J¼15.9 Hz, 1H, H-3), 7.32–7.43 (m, 6H,